XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
License and Collaboration Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Product revenues, net $ 309,322 $ 207,774 $ 779,805 $ 607,836  
Cost of sales (excluding amortization of in-licensed rights) 37,026 39,952 106,167 109,190  
Development Milestone and Upfront Fee Recognized as Research and Development Expense 3,800 5,500 11,900 14,300  
Collaborative Arrangement          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Payment for option exercise     221,300    
Research, option and milestone expense 3,800 6,000 3,800 6,000  
Collaborative Arrangement | Maximum [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Contingent research milestone payments     36,100    
Development Milestone and Settlement Upfront Fee Recognized as Research and Development Expense 3,200,000   3,200,000    
Collaborative Arrangement | Research and Development Expense [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Up-front and development milestone expenses   5,000 7,500 5,000  
Collaborative Arrangement | Roche Holding A.G. [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Product revenues, net 22,500 66,800 22,500 66,800  
Deferred Revenue 507,500   507,500    
Deferred Revenue, Current 22,500   22,500    
Deferred Revenue Separate Material Options Right 485,000   485,000   $ 485,000
Research and development expense 34,900 $ 22,000 83,400 $ 66,100  
Collaboration Receivable 35,400   35,400    
Nationwide License Agreement [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Licensed Right Intangible Asset 2,000   2,000    
Carrying value 2,000   2,000    
Cost of sales (excluding amortization of in-licensed rights) 2,100   2,100    
Nationwide License Agreement [Member] | Nationwide Childrens Hospital [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Sales milestone payment recorded as an in-license right 9,800   9,800    
Carrying value $ 10,000   $ 10,000